ASAndrew Smart

Andrew Smart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew Smart has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • George T.H. Ellison

    University of London, Cranmer Terrace, London SW17 0RE, UK

    2 shared publications
  • Kate Weiner

    Department of Sociological Studies University of Sheffield Sheffield UK

    2 shared publications
  • Paul Martin

    Institute for Science and Society, University of Nottingham, University Park, Nottingham NG7 2RD, UK

    2 shared publications
  • Richard Ashcroft

    School of Law, Queen Mary, University of London, London E1 4NS, UK

    2 shared publications
  • Richard Tutton

    Institute for Advanced Studies, Lancaster University, County South, Lancaster LA1 4YD, UK

    2 shared publications
  • Alessandro Musenga

    Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne‐Geneva, Lausanne University Hospital University of Lausanne Épalinges Switzerland

    1 shared publication

Latest Publications

  • Open Access

    Ethico‐racial positioning in campaigns for COVID‐19 research and vaccination featuring public figures

    by Andrew Smart, Ros Williams, Kate Weiner, Lijiaozi Cheng, Francesca Sobande

    This article analyses a set of videos which featured public figures encouraging racially minoritised people in the UK to take the COVID‐19 vaccine or get involved in related research. As racially targeted health communication has both potentially beneficial and problematic consequences, it is important to examine this uniquely high‐profile case. Using a purposive sample of 10 videos, our thematic content analysis aimed to reveal how racially minoritised people were represented and the types of concerns about the vaccine that were expressed. We found representations of racialised difference that centred on ‘community’ and invoked shared social experiences. The expressed concerns centred on whether ethnic difference was accounted for in the vaccine’s design and development, plus the overarching issue of trust. Our analysis adopts and develops the concept of ‘racialisation’; we explore how ‘mutuality’ underpinned normative calls to action (‘ethico‐racial imperatives’) and how the videos ‘responsibilised’ racially minoritised people. We discuss two points of tension in this case: the limitations for addressing the causes of mistrust and the risks of reductivism that accompanied the ambiguous notion of community. Our analysis develops scholarship on racialisation in health contexts and provides public health practitioners with insights into the socio‐political considerations of racially targeted communications.


  • Open Access

    Stability of drugs of abuse in synthetic oral fluid investigated using a simple “dilute and inject” method of analysis

    by Ivana Gavrilović, Alessandro Musenga, Kim Wolff, Alison Woffendin, Andrew Smart, Fan Gong, Duncan Harding, David Cowan

    Human oral fluid is well established as a matrix for drug screening, particularly in the workplace. The need to synthesise synthetic oral fluid (SOF) has been recognised in order to overcome human oral fluid's composition variability. We have used SOF spiked with six common drugs of abuse or their primary metabolites: morphine, amfetamine, benzoylecgonine, cocaine, diazepam, and (−)‐Δ9‐tetrahydrocannabinol (THC) in order to assess the suitability of this matrix for quality assurance purposes. For confirmation of a drug screening test, controls and spiked standards are normally required. All our analytes were detected by LC–MS/MS using a quick and easy “dilute and inject” sample preparation approach as opposed to relatively slower solid‐phase extraction. The limit of detection (LOD) was 10 ng/ml for diazepam and THC and 5 ng/ml for morphine, amfetamine, benzoylecgonine and cocaine. Validation results showed good accuracy as well as inter‐ and intra‐assay precision (CV [%] < 5). Our work highlighted the importance of adding Tween® 20 to the SOF and calibrants to reduce losses when handling THC. Furthermore, drug stability was tested at various temperatures (5°C, 20°C and 40°C), for a number of days or after freeze–thaw cycles. Recommendations regarding storage are provided, the spiked SOF being stable at 5°C for up to 1 week without significant drug concentration loss.


  • Open Access

    Racialised prescribing: enacting race/ethnicity in clinical practice guidelines and in accounts of clinical practice

    by Andrew Smart, Kate Weiner

    This article examines the articulation and enactment of racialised classifications in clinical practice guidelines and in accounts of clinical practice. It contributes to debates about racialisation in medicine and its consequences. The research centred on the case study of prescribing guidelines for hypertension in England and Wales, drawing on documentary sources and semi‐structured expert interviews. We found that conceptual and socio‐political uncertainties existed about how to interpret the designation ‘Black patients’ and about the practices for identifying patients’ race/ethnicity. To ‘close’ uncertainties, and thus produce the guidelines and treat patients, respondents drew authority from disparate elements of the ‘topologies of race’. This has implications for understanding processes of racialisation and for the future use of racialised clinical practice guidelines. We argue that clinical practice guidelines play a ‘nodal’ role in racialisation by forming an authoritative material connection that creates a path for translating racialised research into racialised healthcare practice, and that they carry with them implicit conceptual and socio‐political uncertainties that are liable to create inconsistencies in healthcare practice.


  • Open Access

    Health and genetic ancestry testing: time to bridge the gap

    by Andrew Smart, Deborah A. Bolnick, Richard Tutton

    It is becoming increasingly difficult to keep information about genetic ancestry separate from information about health, and consumers of genetic ancestry tests are becoming more aware of the potential health risks associated with particular ancestral lineages. Because some of the proposed associations have received little attention from oversight agencies and professional genetic associations, scientific developments are currently outpacing governance regimes for consumer genetic testing. We highlight the recent and unremarked upon emergence of biomedical studies linking markers of genetic ancestry to disease risks, and show that this body of scientific research is becoming part of public discourse connecting ancestry and health. For instance, data on genome-wide ancestry informative markers are being used to assess health risks, and we document over 100 biomedical research articles that propose associations between mitochondrial DNA and Y chromosome markers of genetic ancestry and a wide variety of disease risks. Taking as an example an association between coronary heart disease and British men belonging to Y chromosome haplogroup I, we show how this science was translated into mainstream and online media, and how it circulates among consumers of genetic tests for ancestry. We find wide variations in how the science is interpreted, which suggests the potential for confusion or misunderstanding. We recommend that stakeholders involved in creating and using estimates of genetic ancestry reconsider their policies for communicating with each other and with the public about the health implications of ancestry information.


  • The under-representation of minority ethnic groups in UK medical research

    by Andrew Smart, Eric Harrison

    Objectives . The paper investigates differences in engagement with medical research between White British and Black, Asian and Minority Ethnic (BAME) groups in the UK, using data from the Wellcome Trust Monitor (WTM). Design. The study used two waves of the WTM (n = 2575) to examine associations between ethnic group and participation in medical research, and willingness to participate (WP) in medical research. Logistic regression models controlled for socio-economic and demographic factors, and relevant outlooks and experiences that are assumed to be markers of engagement. Results. Respondents from the BAME group were less likely to have participated in medical research compared to those from the White British group, but there was only patchy evidence of small ethnic group differences in WP. Influences on engagement with medical research varied somewhat between the White British and BAME groups, in particular in relation to occupation, education, health, attitudes to medical science and belief. Conclusions. These findings consolidate previously context-specific evidence of BAME group under-representation in the UK, and highlight heterogeneity in that group. Efforts to address the under-representation of those from BAME groups might benefit from targeted strategies for recruitment and advocacy, although improved data sets are required to fully understand ethnic differences in engagement with medical research.


  • Constructions of collective Muslim identity by advocates of Muslim schools in Britain

    by Claire Tinker, Andrew Smart

    This paper considers how and why collective Muslim identity is expressed and mobilized by advocates of Muslim schools in Britain. This relates to broader questions about the conceptualization, construction and meanings of Muslim identities, and the problem of essentialism that can arise when reporting identity claims that emphasize intra-group unity. Analysis of data from interviews with stakeholders in the debate about Muslim schools in Britain revealed advocates commonly regarded separate schooling as a protective measure against threats to and/or attacks on Muslim identity. It is argued that interviewees invoked collective Muslim identity in ways that drew attention to common knowledge, values and practice, and/or shared life experiences relating to denigrated or discordant social identities. The commonalities expressed by respondents are interpreted as evidence of a convergence of identities and interests in particular social conditions, and are not claimed to be essential characteristics of collective Muslim identity.


  • Impediments to DNA Testing and Cascade Screening for Hypertrophic Cardiomyopathy and Long QT syndrome: A Qualitative Study of Patient Experiences

    by Andrew Smart

    This paper reports data from a qualitative study of patient experiences of DNA testing and cascade screening for hypertrophic cardiomyopathy and long QT syndrome, cardiac conditions that place sufferers at risk of sudden death. The paper particularly focuses on potential impediments to testing and screening. Semi‐structured interviews were undertaken with a purposive sample of 27 people in the UK who had undergone testing. In the context of the uncertainties that can characterize experiences of these disorders, the majority of participants in this sample embraced testing and screening as a way of providing health information for themselves or their relatives (particularly children). There was nevertheless evidence of ambivalence about the value and impact of the DNA test information which could influence participants’ dispositions toward testing, and play into dilemmas about family communication. Other concerns arose in relation to communicating about these disorders, decisions to involve elderly relatives and pressures relating to family responsibility. The evidence of ambivalence provides insight into why some people may be resistant to testing, screening and sharing information. The findings about communication processes indicate potential areas of concern for the cascading process.


  • Open Access

    The Standardization of Race and Ethnicity in Biomedical Science Editorials and UK Biobanks

    by Andrew Smart, Richard Tutton, Paul Martin, George T.H. Ellison, Richard Ashcroft

    As the search for human genetic variation has become a priority for biomedical science, debates have resurfaced about the use of race and ethnicity as scientific classifications. In this paper we consider the relationship between race, ethnicity and genetics, using insights from science and technology studies (STS) about processes of classification and standardization. We examine how leading biomedical science journals attempted to standardize the classifications of race and ethnicity, and analyse how a sample of UK genetic scientists used the concepts in their research. Our content analysis of 11 editorials and related guidelines reveals variations in the guidance on offer, and it appears that there has been a shift from defining the concepts to prescribing methodological processes for classification. In qualitative interviews with 17 scientists, the majority reported that they had adopted socio-political classification schemes from state bureaucracy (for example, the UK Census) for practical reasons, although some scientists used alternative classifications that they justified on apparently methodological grounds. The different responses evident in the editorials and interviews can be understood as reflecting the balance of flexibility and stability that motivate standardization processes. We argue that, although a genetic concept of race and ethnicity is unlikely to wholly supplant a socio-political one, the adoption of census classifications into biomedical research is an alignment of state bureaucracy and science that could have significant consequences.


  • Governing Genetic Databases: Challenges Facing Research Regulation and Practice

    by Susan M.C. Gibbons, Jane Kaye, Andrew Smart, Catherine Heeney, Michael Parker